Literature DB >> 18603686

Sequence analysis of bla CTX-M-28 , an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India.

Jemima Kingsley1, Susan Verghese.   

Abstract

The most common group of ESBLs not belonging to the bla TEM or bla SHV families were termed bla CTX-M , to highlight their ESBLs' greater activity against cefotaxime than against ceftazidime. The presence of nosocomial bla CTX-M-28 -producing Enterobacteriaceae strains has not been reported earlier in Indian hospitals. The sequences of bla CTX-M-28 gene from cephalosporin-resistant Enterobacteriaceae were analyzed. The structural gene encodes a 290 amino-acid protein, which is most related to the bla CTX-M beta-lactamases. The conserved K-T-G was identified in the bla CTX-M-28 protein sequence, but significantly, two point mutations (N-->T) and (F-->S) were identified in the Y-G-N- and S-T-F-K-conserved motifs respectively. These point mutations were seen in all the three sequenced isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603686     DOI: 10.4103/0377-4929.41691

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Occurrence of the CTX-M, SHV and the TEM Genes Among the Extended Spectrum β-Lactamase Producing Isolates of Enterobacteriaceae in a Tertiary Care Hospital of North India.

Authors:  Maninder Kaur; Aruna Aggarwal
Journal:  J Clin Diagn Res       Date:  2013-04-01

2.  First Report of blaCTX-M-28 in Enterobacteriaceae Isolates in the United Arab Emirates.

Authors:  Mubarak Alfaresi; Garwin Kim Sing; Abiola Senok
Journal:  J Pathog       Date:  2018-01-18

3.  Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India.

Authors:  Vikas Gautam; Anjana Thakur; Megha Sharma; Avinash Singh; Shruti Bansal; Aditi Sharma; Arti Kapil; Bimal Kumar Das; Sujatha Sistla; Subhash Chandra Parija; Balaji Veeraraghavan; John Antony Jude Prakash; Kamini Walia; V C Ohri; Pallab Ray
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.